Dulaglutide
Trulicity
Half-life
5 days
Time to Peak
2 days
Steady State
~25 days
Bioavailability
65%
Dose Range
0.75–4.5 mg
Frequency
Weekly
Overview
Once-weekly injectable GLP-1 receptor agonist for type 2 diabetes. Pre-filled single-use pen with hidden needle designed to reduce injection anxiety.
Mechanism of Action
GLP-1 receptor agonist fused to modified IgG4-Fc fragment. The larger molecular size extends the half-life to ~5 days.
Dosing Information
| Route | Dose Range | Half-life | Tmax | Frequency |
|---|---|---|---|---|
| Subcutaneous (SubQ) | 0.75–4.5 mg | 5 days | 2 days | Weekly |
Storage & Handling
2-8C — Refrigerate. Can store at room temp (up to 30C) for up to 14 days. Do not freeze.
Used in Regimens
Dulaglutide is not currently part of any catalog regimen.
Data Sources
- FDA Label Trulicity FDA Prescribing Information
Related Tools
Track Dulaglutide with Doseline
Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.